Antibiotic resistance (ABR) has arisen as a critical concern in contemporary
healthcare, significantly impacting patient outcomes, healthcare systems, and worldwide public
health. As bacteria develop resistance to widely utilized antibiotics, infections become
progressively challenging to manage, leading to prolonged hospitalizations, elevated treatment
expenses, and heightened morbidity and fatality rates. This study examines the effects of ABR on
healthcare outcomes, encompassing clinical, economic, and systemic difficulties it poses. The
paper emphasizes the significance of antimicrobial stewardship programs in alleviating these
consequences and offers recommendations for improving existing hospital policies and
procedures.

" /> Antibiotic resistance (ABR) has arisen as a critical concern in contemporary
healthcare, significantly impacting patient outcomes, healthcare systems, and worldwide public
health. As bacteria develop resistance to widely utilized antibiotics, infections become
progressively challenging to manage, leading to prolonged hospitalizations, elevated treatment
expenses, and heightened morbidity and fatality rates. This study examines the effects of ABR on
healthcare outcomes, encompassing clinical, economic, and systemic difficulties it poses. The
paper emphasizes the significance of antimicrobial stewardship programs in alleviating these
consequences and offers recommendations for improving existing hospital policies and
procedures.

" /> Antibiotic resistance (ABR) has arisen as a critical concern in contemporary
healthcare, significantly impacting patient outcomes, healthcare systems, and worldwide public
health. As bacteria develop resistance to widely utilized antibiotics, infections become
progressively challenging to manage, leading to prolonged hospitalizations, elevated treatment
expenses, and heightened morbidity and fatality rates. This study examines the effects of ABR on
healthcare outcomes, encompassing clinical, economic, and systemic difficulties it poses. The
paper emphasizes the significance of antimicrobial stewardship programs in alleviating these
consequences and offers recommendations for improving existing hospital policies and
procedures.

" />

IMPACT OF ANTIBIOTIC RESISTANCE ON HEALTHCARE OUTCOMES



Chop etilgan sana:

PDF
Imran Aslam
Research Assistant & Assistant Professor, Department of Pharmacology Samarkand State Medical University
Ayesha Ashraf
Assistant Professor, Department of Public Health Samarkand State Medical University

Abstract

Antibiotic resistance (ABR) has arisen as a critical concern in contemporary
healthcare, significantly impacting patient outcomes, healthcare systems, and worldwide public
health. As bacteria develop resistance to widely utilized antibiotics, infections become
progressively challenging to manage, leading to prolonged hospitalizations, elevated treatment
expenses, and heightened morbidity and fatality rates. This study examines the effects of ABR on
healthcare outcomes, encompassing clinical, economic, and systemic difficulties it poses. The
paper emphasizes the significance of antimicrobial stewardship programs in alleviating these
consequences and offers recommendations for improving existing hospital policies and
procedures.

Foydalangan adabiyotlar

1. Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J.,
2. ... & Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: Guidelines by the
3. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of
4. America. Clinical Infectious Diseases, 62(10), e51-e77.
5. Baxter, C. G., Russell, C., Duncan, H., Farrell, S., Law, S., Baker, J., & Denning, D. W. (2016).
6. Clinical and laboratory features of invasive aspergillosis and the significance of aspergillus in
7. respiratory samples in acute leukaemia and haematopoietic stem cell transplantation. British
8. Journal of Haematology, 139(3), 504-515.
9. Centers for Disease Control and Prevention (2019). Antibiotic resistance threats in the United
10. States. Retrieved from https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threatsreport-508.pdf
11. Cosgrove, S. E., & Carmeli, Y. (2003). The impact of antimicrobial resistance on health and
12. economic outcomes. Clinical Infectious Diseases, 36(11), 1433-1437.
13. Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., ...
14. & Hooton, T. M. (2007). Infectious Diseases Society of America and the Society for Healthcare
15. Epidemiology of America guidelines for developing an institutional program to enhance
16. antimicrobial stewardship. Clinical Infectious Diseases, 44(2), 159-177.
17. Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017). What is antimicrobial stewardship?
18. Clinical Microbiology and Infection, 23(11), 793-798.
19. Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., ... &
20. Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial
21. resistance. The Lancet, 387(10014), 176-187.
22. Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF
23. INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED
24. CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of
25. Medical Education: Experience, Problems, Prospects, 66.
26. Jiyanboevich, Y. S., Aslam, I., & Soatboyevich, J. N. (2024). FAILURE OF THE HEART
27. DETERMINATION PROTEOMIC PROFILING RELATED TO PATIENTS WHO ARE
28. ELDERLY. Research Focus, 3(1), 198-203.
29. Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating
30. Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and
31. Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141.
32. Shahzoda, K., Aslam, I., Ashraf, A., Ergashboevna, A. Z., & Ergashboevna, E. M. (2024).
33. ADVANCEMENTS IN SURGICAL TECHNIQUES: A COMPREHENSIVE
34. REVIEW. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va
35. rivojlanish omillari, 31(2), 139-149.RESEARCH FOCUS | VOLUME 3 | ISSUE 10 | 2024
36. ISSN: 2181-3833 ResearchBip (12.32) | Google Scholar | Index Copernicus (ICV69.78)
37. Research Focus International Scientific Journal, Uzbekistan 138 https://refocus.uz/
38. Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF
39. INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED
40. CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of
41. Medical Education: Experience, Problems, Prospects, 66.
42. Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating
43. Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and
44. Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141.
45. Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood
46. Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and
47. Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.
48. Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood
49. Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and
50. Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.

Izlang

Izlash

Issue

Research Focus International Scientific Journal 3 (10)

Bo'lim

14.00.00 – Medical sciences

So'ngi nashrlar